Do analysts recommend ADGM or HSAQ?

Adagio Medical currently has a consensus price target of $3.50, suggesting a potential upside of 570.50%. Given Adagio Medical's stronger consensus rating and higher probable upside, analysts clearly believe Adagio Medical is more favorable than Health Sciences Acquisitions Co. 2. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adagio Medical 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Health Sciences Acquisitions Co. 2 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher valuation & earnings, ADGM or HSAQ?

Health Sciences Acquisitions Co. 2 has lower revenue, but higher earnings than Adagio Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Adagio Medical $600K 19.32 -$25.08M -$1.48 N/A Health Sciences Acquisitions Co. 2 N/A N/A -$380K N/A N/A

Is ADGM or HSAQ more profitable?

Health Sciences Acquisitions Co. 2's return on equity of 0.00% beat Adagio Medical's return on equity. Company Net Margins Return on Equity Return on Assets Adagio Medical N/A -661.85% -73.35% Health Sciences Acquisitions Co. 2 N/A N/A -2.38%

Does the media refer more to ADGM or MDAI?

In the previous week, Spectral AI had 4 more articles in the media than Adagio Medical. MarketBeat recorded 7 mentions for Spectral AI and 3 mentions for Adagio Medical. Adagio Medical's average media sentiment score of 0.62 beat Spectral AI's score of 0.33 indicating that Adagio Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adagio Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Spectral AI 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to ADGM or SRTS?

In the previous week, Sensus Healthcare had 3 more articles in the media than Adagio Medical. MarketBeat recorded 6 mentions for Sensus Healthcare and 3 mentions for Adagio Medical. Sensus Healthcare's average media sentiment score of 1.45 beat Adagio Medical's score of 0.62 indicating that Sensus Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adagio Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sensus Healthcare 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate ADGM or POCI?

Adagio Medical currently has a consensus target price of $3.50, indicating a potential upside of 570.50%. Given Adagio Medical's stronger consensus rating and higher probable upside, research analysts clearly believe Adagio Medical is more favorable than Precision Optics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adagio Medical 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Precision Optics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media prefer ADGM or POCI?

In the previous week, Adagio Medical had 1 more articles in the media than Precision Optics. MarketBeat recorded 3 mentions for Adagio Medical and 2 mentions for Precision Optics. Precision Optics' average media sentiment score of 0.94 beat Adagio Medical's score of 0.62 indicating that Precision Optics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adagio Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Precision Optics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate BDMD or ADGM?

Adagio Medical has a consensus target price of $3.50, suggesting a potential upside of 570.50%. Given Adagio Medical's stronger consensus rating and higher probable upside, analysts clearly believe Adagio Medical is more favorable than Baird Medical Investment. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Baird Medical Investment 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Adagio Medical 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Which has higher earnings and valuation, BDMD or ADGM?

Baird Medical Investment has higher revenue and earnings than Adagio Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Baird Medical Investment $22.54M 2.15 N/A N/A N/A Adagio Medical $600K 19.32 -$25.08M -$1.48 N/A

Is BDMD or ADGM more profitable?

Baird Medical Investment's return on equity of 0.00% beat Adagio Medical's return on equity. Company Net Margins Return on Equity Return on Assets Baird Medical Investment N/A N/A N/A Adagio Medical N/A -661.85% -73.35%

Does the media prefer BDMD or ADGM?

In the previous week, Baird Medical Investment had 4 more articles in the media than Adagio Medical. MarketBeat recorded 7 mentions for Baird Medical Investment and 3 mentions for Adagio Medical. Adagio Medical's average media sentiment score of 0.62 beat Baird Medical Investment's score of 0.42 indicating that Adagio Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baird Medical Investment 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Adagio Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Adagio Medical (ADGM) Competitors

$0.52 -0.03 (-5.09%)

As of 04:00 PM Eastern

Compare

ADGM vs. HSAQ, MDAI, SRTS, POCI, and BDMD

Should you buy Adagio Medical stock or one of its competitors? Adagio Medical's main competitors and comparable companies include Health Sciences Acquisitions Co. 2 (HSAQ), Spectral AI (MDAI), Sensus Healthcare (SRTS), Precision Optics (POCI), and Baird Medical Investment (BDMD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Adagio Medical compare to Health Sciences Acquisitions Co. 2?

Adagio Medical (NASDAQ:ADGM) and Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, media sentiment, analyst recommendations and dividends.

Health Sciences Acquisitions Co. 2's return on equity of 0.00% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adagio Medical	N/A	-661.85%	-73.35%
Health Sciences Acquisitions Co. 2	N/A	N/A	-2.38%

Adagio Medical has a beta of -0.15, suggesting that its stock price is 115% less volatile than the broader market. Comparatively, Health Sciences Acquisitions Co. 2 has a beta of 0.09, suggesting that its stock price is 91% less volatile than the broader market.

In the previous week, Adagio Medical had 3 more articles in the media than Health Sciences Acquisitions Co. 2. MarketBeat recorded 3 mentions for Adagio Medical and 0 mentions for Health Sciences Acquisitions Co. 2. Adagio Medical's average media sentiment score of 0.62 beat Health Sciences Acquisitions Co. 2's score of 0.00 indicating that Adagio Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Adagio Medical	Positive
Health Sciences Acquisitions Co. 2	Neutral

Adagio Medical currently has a consensus price target of $3.50, suggesting a potential upside of 570.50%. Given Adagio Medical's stronger consensus rating and higher probable upside, analysts clearly believe Adagio Medical is more favorable than Health Sciences Acquisitions Co. 2.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Health Sciences Acquisitions Co. 2	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Health Sciences Acquisitions Co. 2 has lower revenue, but higher earnings than Adagio Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adagio Medical	$600K	19.32	-$25.08M	-$1.48	N/A
Health Sciences Acquisitions Co. 2	N/A	N/A	-$380K	N/A	N/A

48.1% of Adagio Medical shares are owned by institutional investors. Comparatively, 89.7% of Health Sciences Acquisitions Co. 2 shares are owned by institutional investors. 7.8% of Adagio Medical shares are owned by company insiders. Comparatively, 21.9% of Health Sciences Acquisitions Co. 2 shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Adagio Medical and Health Sciences Acquisitions Co. 2 tied by winning 6 of the 12 factors compared between the two stocks.

How does Adagio Medical compare to Spectral AI?

Adagio Medical (NASDAQ:ADGM) and Spectral AI (NASDAQ:MDAI) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation, media sentiment and analyst recommendations.

Adagio Medical has a net margin of 0.00% compared to Spectral AI's net margin of -69.27%. Spectral AI's return on equity of 0.00% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adagio Medical	N/A	-661.85%	-73.35%
Spectral AI	-69.27%	N/A	-78.56%

Adagio Medical currently has a consensus price target of $3.50, suggesting a potential upside of 570.50%. Spectral AI has a consensus price target of $4.00, suggesting a potential upside of 148.45%. Given Adagio Medical's higher probable upside, equities research analysts clearly believe Adagio Medical is more favorable than Spectral AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

In the previous week, Spectral AI had 4 more articles in the media than Adagio Medical. MarketBeat recorded 7 mentions for Spectral AI and 3 mentions for Adagio Medical. Adagio Medical's average media sentiment score of 0.62 beat Spectral AI's score of 0.33 indicating that Adagio Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Adagio Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Spectral AI	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Adagio Medical has a beta of -0.15, suggesting that its stock price is 115% less volatile than the broader market. Comparatively, Spectral AI has a beta of 1.18, suggesting that its stock price is 18% more volatile than the broader market.

48.1% of Adagio Medical shares are owned by institutional investors. Comparatively, 67.1% of Spectral AI shares are owned by institutional investors. 7.8% of Adagio Medical shares are owned by insiders. Comparatively, 13.7% of Spectral AI shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Spectral AI has higher revenue and earnings than Adagio Medical. Spectral AI is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adagio Medical	$600K	19.32	-$25.08M	-$1.48	N/A
Spectral AI	$19.65M	2.64	-$7.57M	-$0.35	N/A

Summary

Spectral AI beats Adagio Medical on 10 of the 16 factors compared between the two stocks.

How does Adagio Medical compare to Sensus Healthcare?

Adagio Medical (NASDAQ:ADGM) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, media sentiment, institutional ownership, risk, earnings and dividends.

Adagio Medical presently has a consensus target price of $3.50, suggesting a potential upside of 570.50%. Sensus Healthcare has a consensus target price of $5.83, suggesting a potential upside of 77.30%. Given Adagio Medical's higher possible upside, analysts plainly believe Adagio Medical is more favorable than Sensus Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

48.1% of Adagio Medical shares are held by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are held by institutional investors. 7.8% of Adagio Medical shares are held by insiders. Comparatively, 10.2% of Sensus Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Adagio Medical has a net margin of 0.00% compared to Sensus Healthcare's net margin of -88.45%. Sensus Healthcare's return on equity of -21.57% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adagio Medical	N/A	-661.85%	-73.35%
Sensus Healthcare	-88.45%	-21.57%	-19.20%

In the previous week, Sensus Healthcare had 3 more articles in the media than Adagio Medical. MarketBeat recorded 6 mentions for Sensus Healthcare and 3 mentions for Adagio Medical. Sensus Healthcare's average media sentiment score of 1.45 beat Adagio Medical's score of 0.62 indicating that Sensus Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Adagio Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sensus Healthcare	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Sensus Healthcare has higher revenue and earnings than Adagio Medical. Sensus Healthcare is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adagio Medical	$600K	19.32	-$25.08M	-$1.48	N/A
Sensus Healthcare	$27.48M	1.97	-$7.72M	-$0.94	N/A

Adagio Medical has a beta of -0.15, suggesting that its stock price is 115% less volatile than the broader market. Comparatively, Sensus Healthcare has a beta of 1.1, suggesting that its stock price is 10% more volatile than the broader market.

Summary

Sensus Healthcare beats Adagio Medical on 11 of the 15 factors compared between the two stocks.

How does Adagio Medical compare to Precision Optics?

Adagio Medical (NASDAQ:ADGM) and Precision Optics (NASDAQ:POCI) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, media sentiment, risk and analyst recommendations.

Precision Optics has higher revenue and earnings than Adagio Medical. Precision Optics is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adagio Medical	$600K	19.32	-$25.08M	-$1.48	N/A
Precision Optics	$19.09M	2.49	-$5.78M	-$0.63	N/A

In the previous week, Adagio Medical had 1 more articles in the media than Precision Optics. MarketBeat recorded 3 mentions for Adagio Medical and 2 mentions for Precision Optics. Precision Optics' average media sentiment score of 0.94 beat Adagio Medical's score of 0.62 indicating that Precision Optics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Adagio Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Precision Optics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Adagio Medical has a net margin of 0.00% compared to Precision Optics' net margin of -17.03%. Precision Optics' return on equity of -37.47% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adagio Medical	N/A	-661.85%	-73.35%
Precision Optics	-17.03%	-37.47%	-19.96%

48.1% of Adagio Medical shares are held by institutional investors. Comparatively, 13.7% of Precision Optics shares are held by institutional investors. 7.8% of Adagio Medical shares are held by company insiders. Comparatively, 14.4% of Precision Optics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Adagio Medical has a beta of -0.15, suggesting that its share price is 115% less volatile than the broader market. Comparatively, Precision Optics has a beta of 0.34, suggesting that its share price is 66% less volatile than the broader market.

Adagio Medical currently has a consensus target price of $3.50, indicating a potential upside of 570.50%. Given Adagio Medical's stronger consensus rating and higher probable upside, research analysts clearly believe Adagio Medical is more favorable than Precision Optics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Precision Optics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Precision Optics beats Adagio Medical on 8 of the 15 factors compared between the two stocks.

How does Adagio Medical compare to Baird Medical Investment?

Baird Medical Investment (NASDAQ:BDMD) and Adagio Medical (NASDAQ:ADGM) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, institutional ownership, valuation, risk, dividends and media sentiment.

Baird Medical Investment's return on equity of 0.00% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baird Medical Investment	N/A	N/A	N/A
Adagio Medical	N/A	-661.85%	-73.35%

Baird Medical Investment has higher revenue and earnings than Adagio Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baird Medical Investment	$22.54M	2.15	N/A	N/A	N/A
Adagio Medical	$600K	19.32	-$25.08M	-$1.48	N/A

Baird Medical Investment has a beta of -1.16, suggesting that its stock price is 216% less volatile than the broader market. Comparatively, Adagio Medical has a beta of -0.15, suggesting that its stock price is 115% less volatile than the broader market.

19.8% of Baird Medical Investment shares are owned by institutional investors. Comparatively, 48.1% of Adagio Medical shares are owned by institutional investors. 78.9% of Baird Medical Investment shares are owned by company insiders. Comparatively, 7.8% of Adagio Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Adagio Medical has a consensus target price of $3.50, suggesting a potential upside of 570.50%. Given Adagio Medical's stronger consensus rating and higher probable upside, analysts clearly believe Adagio Medical is more favorable than Baird Medical Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baird Medical Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

In the previous week, Baird Medical Investment had 4 more articles in the media than Adagio Medical. MarketBeat recorded 7 mentions for Baird Medical Investment and 3 mentions for Adagio Medical. Adagio Medical's average media sentiment score of 0.62 beat Baird Medical Investment's score of 0.42 indicating that Adagio Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baird Medical Investment	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Adagio Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Adagio Medical beats Baird Medical Investment on 7 of the 12 factors compared between the two stocks.

Get Adagio Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADGM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ADGM vs. The Competition

Export

Metric	Adagio Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$12.22M	$5.79B	$7.30B	$12.80B
Dividend Yield	N/A	1.74%	2.54%	10.79%
P/E Ratio	N/A	26.01	272.76	24.14
Price / Sales	19.32	44.53	630.69	98.18
Price / Cash	N/A	33.27	78.57	53.12
Price / Book	-26.10	6.24	13.14	6.23
Net Income	-$25.08M	$149.10M	$3.47B	$348.07M
7 Day Performance	-17.41%	0.53%	1.38%	0.67%
1 Month Performance	8.30%	9.26%	8.62%	4.84%
1 Year Performance	-62.98%	6.82%	25.90%	16.83%

Adagio Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ADGM Adagio Medical	2.341 of 5 stars	$0.52 -5.1%	$3.50 +570.5%	-56.7%	$12.22M	$600K	N/A	87	News Coverage Short Interest Increase
HSAQ Health Sciences Acquisitions Co. 2	N/A	$4.72 +7.0%	N/A	+113.3%	$52.92M	N/A	N/A	4
MDAI Spectral AI	3.1187 of 5 stars	$1.61 -0.3%	$4.00 +149.2%	-19.7%	$51.20M	$19.65M	N/A	83	Analyst Downgrade
SRTS Sensus Healthcare	3.4435 of 5 stars	$3.09 +3.0%	$5.83 +88.8%	+7.3%	$50.86M	$27.48M	N/A	40	News Coverage Insider Trade
POCI Precision Optics	0.772 of 5 stars	$4.39 +1.2%	N/A	-9.1%	$48.04M	$28.94M	N/A	80	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ADGM) was last updated on 8/26/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Adagio Medical (ADGM) Competitors

ADGM vs. HSAQ, MDAI, SRTS, POCI, and BDMD

How does Adagio Medical compare to Health Sciences Acquisitions Co. 2?

Summary

How does Adagio Medical compare to Spectral AI?

Summary

How does Adagio Medical compare to Sensus Healthcare?

Summary

How does Adagio Medical compare to Precision Optics?

Summary

How does Adagio Medical compare to Baird Medical Investment?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADGM vs. The Competition

Adagio Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Adagio Medical (ADGM) Competitors

ADGM vs. HSAQ, MDAI, SRTS, POCI, and BDMD

How does Adagio Medical compare to Health Sciences Acquisitions Co. 2?

Is ADGM or HSAQ more profitable?

Which has more volatility & risk, ADGM or HSAQ?

Does the media refer more to ADGM or HSAQ?

Do analysts recommend ADGM or HSAQ?

Which has higher valuation & earnings, ADGM or HSAQ?

Do insiders & institutionals hold more shares of ADGM or HSAQ?

Summary

How does Adagio Medical compare to Spectral AI?

Is ADGM or MDAI more profitable?

Do analysts recommend ADGM or MDAI?

Does the media refer more to ADGM or MDAI?

Which has more risk & volatility, ADGM or MDAI?

Do institutionals & insiders hold more shares of ADGM or MDAI?

Which has stronger earnings & valuation, ADGM or MDAI?

Summary

How does Adagio Medical compare to Sensus Healthcare?

Do analysts recommend ADGM or SRTS?

Do institutionals and insiders have more ownership in ADGM or SRTS?

Is ADGM or SRTS more profitable?

Does the media refer more to ADGM or SRTS?

Which has stronger earnings & valuation, ADGM or SRTS?

Which has more volatility and risk, ADGM or SRTS?

Summary

How does Adagio Medical compare to Precision Optics?

Which has stronger valuation and earnings, ADGM or POCI?

Does the media prefer ADGM or POCI?

Is ADGM or POCI more profitable?

Do insiders & institutionals believe in ADGM or POCI?

Which has more risk & volatility, ADGM or POCI?

Do analysts rate ADGM or POCI?

Summary

How does Adagio Medical compare to Baird Medical Investment?

Is BDMD or ADGM more profitable?

Which has higher earnings and valuation, BDMD or ADGM?

Which has more risk and volatility, BDMD or ADGM?

Do institutionals & insiders hold more shares of BDMD or ADGM?

Do analysts rate BDMD or ADGM?

Does the media prefer BDMD or ADGM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADGM vs. The Competition

Adagio Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools